Full Text
How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

Abstract

Authors

L Pibouleau A Drezet M Cognet O Scemama C Le galès

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×